Designer, manufacturer and distributor of biological research equipment based on integrated fluidic circuit technology. The company's biological research equipment leverage the capabilities of multilayer soft lithography to create microfluidic devices, enabling companies in protein crystallization, genetic analysis as well as help them in exploration and analysis of individual cells.
Profitable
Publicly Held
Formerly VC-backed
The company (NAS: FLDM) received $66.29 million of development capital from Adage Capital Management, Levin Capital Strategies, Metropolitan Life Insurance Company, Renaissance Technologies and Russell Investments on May 6, 2017 through a private placement.
Add a review